Bluejay Diagnostics (BJDX) Capital Expenditures (2021 - 2026)
Bluejay Diagnostics (BJDX) posted Capital Expenditures of $18989.0 for Q1 2026, down 90.52% sequentially from $200265.0 in Q4 2025, and up 2410.1% YoY from $756.5 in Q1 2025.
Bluejay Diagnostics (BJDX) Capital Expenditures (2021 - 2026) Analysis & Trends
Bluejay Diagnostics has reported Capital Expenditures for 6 years, with the latest figure at $18989.0 in Q1 2026.
- Quarterly Capital Expenditures rose 2410.1% year-over-year to $18989.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $193546.0 (down 28.46% YoY) and the FY2025 annual result came in at $173735.0, down 43.37% from the prior year.
- Capital Expenditures slipped to $18989.0 in Q1 2026 per BJDX's latest filing, from $200265.0 in the prior quarter.
- Over five years, Capital Expenditures peaked at $791464.0 in Q3 2022 and troughed at -$310496.0 in Q3 2024.
- A 5-year average of $99542.9 and a median of -$788.0 in 2022 frame the typical range for Capital Expenditures.
- The widest YoY moves for Capital Expenditures: up 25168.17% in 2024, down 17461.99% in 2024.
- Over 5 years, Capital Expenditures stood at $238207.0 in 2022, then tumbled by 100.52% to -$1244.0 in 2023, then surged by 25168.17% to $311848.0 in 2024, then tumbled by 35.78% to $200265.0 in 2025, then sank by 90.52% to $18989.0 in 2026.
- According to Business Quant data, Capital Expenditures over the past three periods registered $18989.0, $200265.0, and -$13437.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.66 Bn | 197.06 Bn | 7.27 Bn | 497.00 Mn |
| 2 | Stryker | 126.34 Bn | 122.86 Bn | 4.50 Bn | 202.00 Mn |
| 3 | Medtronic | 119.31 Bn | 110.09 Bn | 6.41 Bn | 488.00 Mn |
| 4 | Boston Scientific | 74.08 Bn | 73.54 Bn | 3.85 Bn | 195.00 Mn |
| 5 | Edwards Lifesciences | 51.66 Bn | 47.40 Bn | 1.35 Bn | 66.90 Mn |
| 6 | Dexcom | 35.13 Bn | 33.18 Bn | 830.00 Mn | 84.70 Mn |
| 7 | GE HealthCare Technologies | 33.82 Bn | 31.71 Bn | 2.18 Bn | 100.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -74.39 Mn |
| 9 | Steris | 23.24 Bn | 22.75 Bn | 684.20 Mn | 87.50 Mn |
| 10 | Bluejay Diagnostics | 1.89 Mn | 1.89 Mn | - | 142,773.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 142,773.00 |
| Jun 30, 2026 | 142,773.00 |
| Mar 31, 2026 | 18,989.00 |
| Mar 31, 2026 | 18,989.00 |
| Dec 31, 2025 | 200,265.00 |
| Dec 31, 2025 | 200,265.00 |
| Sep 30, 2025 | -13,437.00 |
| Sep 30, 2025 | -13,437.00 |
| Jun 30, 2025 | -12,271.00 |
| Jun 30, 2025 | -12,271.00 |
| Mar 31, 2025 | -822.00 |
| Mar 31, 2025 | -822.00 |
| Dec 31, 2024 | 311,848.00 |
| Dec 31, 2024 | 311,848.00 |
| Sep 30, 2024 | -310,496.00 |
| Sep 30, 2024 | -310,496.00 |
| Jun 30, 2024 | 269,998.00 |
| Jun 30, 2024 | 269,998.00 |
| Mar 31, 2024 | 35,433.00 |
| Mar 31, 2024 | 35,433.00 |